RHJA
Rice Hall James & Associates’s Akebia Therapeutics AKBA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-513,292
| Closed | -$368K | – | 266 |
|
|
2022
Q1 | $368K | Buy |
513,292
+27,072
| +6% | +$19.4K | 0.01% | 261 |
|
|
2021
Q4 | $1.1M | Sell |
486,220
-79,806
| -14% | -$180K | 0.04% | 242 |
|
|
2021
Q3 | $1.63M | Buy |
566,026
+13,050
| +2% | +$37.6K | 0.06% | 229 |
|
|
2021
Q2 | $2.1M | Sell |
552,976
-24,996
| -4% | -$94.7K | 0.07% | 206 |
|
|
2021
Q1 | $1.96M | Sell |
577,972
-968,197
| -63% | -$3.28M | 0.06% | 220 |
|
|
2020
Q4 | $4.33M | Sell |
1,546,169
-32,910
| -2% | -$92.1K | 0.15% | 111 |
|
|
2020
Q3 | $3.96M | Buy |
1,579,079
+206,191
| +15% | +$517K | 0.16% | 110 |
|
|
2020
Q2 | $18.6M | Sell |
1,372,888
-34,276
| -2% | -$465K | 0.8% | 39 |
|
|
2020
Q1 | $10.7M | Buy |
1,407,164
+8,543
| +0.6% | +$64.8K | 0.6% | 49 |
|
|
2019
Q4 | $8.84M | Sell |
1,398,621
-85,516
| -6% | -$540K | 0.3% | 109 |
|
|
2019
Q3 | $5.82M | Sell |
1,484,137
-9,933
| -0.7% | -$38.9K | 0.21% | 115 |
|
|
2019
Q2 | $7.23M | Sell |
1,494,070
-51,612
| -3% | -$250K | 0.24% | 117 |
|
|
2019
Q1 | $12.7M | Buy |
1,545,682
+324,184
| +27% | +$2.66M | 0.41% | 93 |
|
|
2018
Q4 | $6.76M | Buy |
1,221,498
+1,181,278
| +2,937% | +$6.53M | 0.25% | 112 |
|
|
2018
Q3 | $355K | Buy |
+40,220
| New | +$355K | 0.01% | 281 |
|